Other studies showed that c-Myc was deregulated in pancreatic cancer, and only cytoplasmic c-Myc expression was an independent prognostic biomarker of pancreatic cancer (He et al., 2014; Kalkat et al., 2017). The gene discussed is MYC; the disease is familial pancreatic carcinoma.